SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Nortran's potential blockbuster heart drug
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Chuca Marsh who wrote (3)12/12/1996 3:31:00 AM
From: xray   of 27
 
Thanks for your comments, Chuck. Regarding your last question, all I can say is "Stay Tuned". Our business plan involves licensing our products, often after Phase I clinical trials are complete, or after commencement of Phase II efficacy trials. The issues we address along the way are: maximizing upside potential of our projects, minimizing overall business risk and specific project risk, graduating from equity to licensing revenue for our source of funds, and optimizing our work in drug discovery. We welcome your questions and comments.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News